Retention of antigen on follicular dendritic cells and B lymphocytes through complement-mediated multivalent ligand-receptor interactions: Theory and application to HIV treatment

William S. Hlavacek, Jerome Percus, Ora E. Percus, Alan S. Perelson, Carla Wofsy

Research output: Contribution to journalArticle

Abstract

In HIV-infected patients, large quantities of HIV are associated with follicular dendritic cells (FDCs) in lymphoid tissue. During antiretroviral therapy, most of this virus disappears after six months of treatment, suggesting that FDC-associated virus has little influence on the eventual outcome of long-term therapy. However, a recent theoretical study using a stochastic model for the interaction of HIV with FDCs indicated that some virus may be retained on FDCs for years, where it can potentially reignite infection if treatment is interrupted. In that study, an approximate expression was used to estimate the time an individual virion remains on FDCs during therapy. Here, we determine the conditions under which this approximation is valid, and we develop expressions for the time a virion spends in any bound state and for the effect of rebinding on retention. We find that rebinding, which is influenced by diffusion, may play a major role in retention of HIV on FDCs. We also consider the possibility that HIV is retained on B cells during therapy, which like FDCs also interact with HIV. We find that virus associated with B cells is unlikely to persist during therapy.

Original languageEnglish (US)
Pages (from-to)185-202
Number of pages18
JournalMathematical Biosciences
Volume176
Issue number2
DOIs
StatePublished - 2002

Fingerprint

B Lymphocytes
Follicular Dendritic Cells
Dendritic Cells
Lymphocytes
dendritic cells
Antigens
human immunodeficiency virus
antigen
Receptor
ligand
B-lymphocytes
complement
B-Lymphocytes
Complement
Ligands
HIV
antigens
Therapy
receptors
Viruses

Keywords

  • B lymphocyte
  • Birth-death Markov chain
  • Follicular dendritic cell
  • Human immunodeficiency virus type 1
  • Immune memory
  • Multivalent ligand-receptor binding

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Ecology, Evolution, Behavior and Systematics

Cite this

Retention of antigen on follicular dendritic cells and B lymphocytes through complement-mediated multivalent ligand-receptor interactions : Theory and application to HIV treatment. / Hlavacek, William S.; Percus, Jerome; Percus, Ora E.; Perelson, Alan S.; Wofsy, Carla.

In: Mathematical Biosciences, Vol. 176, No. 2, 2002, p. 185-202.

Research output: Contribution to journalArticle

Hlavacek, William S. ; Percus, Jerome ; Percus, Ora E. ; Perelson, Alan S. ; Wofsy, Carla. / Retention of antigen on follicular dendritic cells and B lymphocytes through complement-mediated multivalent ligand-receptor interactions : Theory and application to HIV treatment. In: Mathematical Biosciences. 2002 ; Vol. 176, No. 2. pp. 185-202.
@article{d290406f65274ca39d4b4feaec5a4b89,
title = "Retention of antigen on follicular dendritic cells and B lymphocytes through complement-mediated multivalent ligand-receptor interactions: Theory and application to HIV treatment",
abstract = "In HIV-infected patients, large quantities of HIV are associated with follicular dendritic cells (FDCs) in lymphoid tissue. During antiretroviral therapy, most of this virus disappears after six months of treatment, suggesting that FDC-associated virus has little influence on the eventual outcome of long-term therapy. However, a recent theoretical study using a stochastic model for the interaction of HIV with FDCs indicated that some virus may be retained on FDCs for years, where it can potentially reignite infection if treatment is interrupted. In that study, an approximate expression was used to estimate the time an individual virion remains on FDCs during therapy. Here, we determine the conditions under which this approximation is valid, and we develop expressions for the time a virion spends in any bound state and for the effect of rebinding on retention. We find that rebinding, which is influenced by diffusion, may play a major role in retention of HIV on FDCs. We also consider the possibility that HIV is retained on B cells during therapy, which like FDCs also interact with HIV. We find that virus associated with B cells is unlikely to persist during therapy.",
keywords = "B lymphocyte, Birth-death Markov chain, Follicular dendritic cell, Human immunodeficiency virus type 1, Immune memory, Multivalent ligand-receptor binding",
author = "Hlavacek, {William S.} and Jerome Percus and Percus, {Ora E.} and Perelson, {Alan S.} and Carla Wofsy",
year = "2002",
doi = "10.1016/S0025-5564(02)00091-3",
language = "English (US)",
volume = "176",
pages = "185--202",
journal = "Mathematical Biosciences",
issn = "0025-5564",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Retention of antigen on follicular dendritic cells and B lymphocytes through complement-mediated multivalent ligand-receptor interactions

T2 - Theory and application to HIV treatment

AU - Hlavacek, William S.

AU - Percus, Jerome

AU - Percus, Ora E.

AU - Perelson, Alan S.

AU - Wofsy, Carla

PY - 2002

Y1 - 2002

N2 - In HIV-infected patients, large quantities of HIV are associated with follicular dendritic cells (FDCs) in lymphoid tissue. During antiretroviral therapy, most of this virus disappears after six months of treatment, suggesting that FDC-associated virus has little influence on the eventual outcome of long-term therapy. However, a recent theoretical study using a stochastic model for the interaction of HIV with FDCs indicated that some virus may be retained on FDCs for years, where it can potentially reignite infection if treatment is interrupted. In that study, an approximate expression was used to estimate the time an individual virion remains on FDCs during therapy. Here, we determine the conditions under which this approximation is valid, and we develop expressions for the time a virion spends in any bound state and for the effect of rebinding on retention. We find that rebinding, which is influenced by diffusion, may play a major role in retention of HIV on FDCs. We also consider the possibility that HIV is retained on B cells during therapy, which like FDCs also interact with HIV. We find that virus associated with B cells is unlikely to persist during therapy.

AB - In HIV-infected patients, large quantities of HIV are associated with follicular dendritic cells (FDCs) in lymphoid tissue. During antiretroviral therapy, most of this virus disappears after six months of treatment, suggesting that FDC-associated virus has little influence on the eventual outcome of long-term therapy. However, a recent theoretical study using a stochastic model for the interaction of HIV with FDCs indicated that some virus may be retained on FDCs for years, where it can potentially reignite infection if treatment is interrupted. In that study, an approximate expression was used to estimate the time an individual virion remains on FDCs during therapy. Here, we determine the conditions under which this approximation is valid, and we develop expressions for the time a virion spends in any bound state and for the effect of rebinding on retention. We find that rebinding, which is influenced by diffusion, may play a major role in retention of HIV on FDCs. We also consider the possibility that HIV is retained on B cells during therapy, which like FDCs also interact with HIV. We find that virus associated with B cells is unlikely to persist during therapy.

KW - B lymphocyte

KW - Birth-death Markov chain

KW - Follicular dendritic cell

KW - Human immunodeficiency virus type 1

KW - Immune memory

KW - Multivalent ligand-receptor binding

UR - http://www.scopus.com/inward/record.url?scp=0036231339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036231339&partnerID=8YFLogxK

U2 - 10.1016/S0025-5564(02)00091-3

DO - 10.1016/S0025-5564(02)00091-3

M3 - Article

C2 - 11916508

AN - SCOPUS:0036231339

VL - 176

SP - 185

EP - 202

JO - Mathematical Biosciences

JF - Mathematical Biosciences

SN - 0025-5564

IS - 2

ER -